{"pmid":32410129,"title":"The Parallel Pandemic: Medical Misinformation and COVID-19 : Primum non nocere.","text":["The Parallel Pandemic: Medical Misinformation and COVID-19 : Primum non nocere.","J Gen Intern Med","Love, Jennifer S","Blumenberg, Adam","Horowitz, Zane","32410129"],"journal":"J Gen Intern Med","authors":["Love, Jennifer S","Blumenberg, Adam","Horowitz, Zane"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410129","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s11606-020-05897-w","topics":["Prevention"],"weight":1,"_version_":1666897319050608641,"score":9.490897,"similar":[{"pmid":32420930,"title":"Primum non nocere. The SARS-CoV-2 pandemic course in oldest.","text":["Primum non nocere. The SARS-CoV-2 pandemic course in oldest.","Dramatic outcomes of Covid-19 pandemia in Italy, in particular in the North, must be discussed. Maybe a bad strategy and lack of timely intervention togheter with concurrent social events, comorbidities of oldest persons, bed rest, inadequate nutritional support and drugs' side effects and infection of health professionals proved fatal for many.","Acta Biomed","Cucinotta, Domenico","32420930"],"abstract":["Dramatic outcomes of Covid-19 pandemia in Italy, in particular in the North, must be discussed. Maybe a bad strategy and lack of timely intervention togheter with concurrent social events, comorbidities of oldest persons, bed rest, inadequate nutritional support and drugs' side effects and infection of health professionals proved fatal for many."],"journal":"Acta Biomed","authors":["Cucinotta, Domenico"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420930","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.23750/abm.v91i2.9624","locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1667254896765698048,"score":100.912964},{"pmid":32245904,"title":"How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.","text":["How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.","New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to rise worldwide. A few reports have showed that mortality due to SARS-CoV-2 is higher in elderly patients and other active comorbidities including cancer. To date, no effective treatment has been identified and management for critically ill patients relies on management in intensive care units. Patients with lung cancer are at risk of pulmonary complications from COVID-19. Furthermore, the use of chemotherapy might have a negative impact in patient's outcome. Therefore, the risk/benefit ratio of systemic anticancer treatment (SACT) has to be considered. For each patient, several factors including age and comorbidities, as well as the number of hospital visits for treatment, can influence this risk. Each hospital around the world has issued some internal policy guidelines for oncologists, aiming to limit risks during this difficult time. We hereby propose a tool to support oncologists and physicians in treatment decision for patients with lung cancer. There are several variables to consider, including the extent of the epidemic, the local healthcare structure capacity, the risk of infection to the individual, the status of cancer, patients' comorbidities, age and details of the treatment. Given this heterogeneity, we have based our suggestions bearing in mind some general factors There is not easy, universal solution to oncological care during this crisis and, to complicate matters, the duration of this pandemic is hard to predict. It is important to weigh the impact of each of our decisions in these trying times rather than rely on routine automatisms.","ESMO Open","Banna, Giuseppe","Curioni-Fontecedro, Alessandra","Friedlaender, Alex","Addeo, Alfredo","32245904"],"abstract":["New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to rise worldwide. A few reports have showed that mortality due to SARS-CoV-2 is higher in elderly patients and other active comorbidities including cancer. To date, no effective treatment has been identified and management for critically ill patients relies on management in intensive care units. Patients with lung cancer are at risk of pulmonary complications from COVID-19. Furthermore, the use of chemotherapy might have a negative impact in patient's outcome. Therefore, the risk/benefit ratio of systemic anticancer treatment (SACT) has to be considered. For each patient, several factors including age and comorbidities, as well as the number of hospital visits for treatment, can influence this risk. Each hospital around the world has issued some internal policy guidelines for oncologists, aiming to limit risks during this difficult time. We hereby propose a tool to support oncologists and physicians in treatment decision for patients with lung cancer. There are several variables to consider, including the extent of the epidemic, the local healthcare structure capacity, the risk of infection to the individual, the status of cancer, patients' comorbidities, age and details of the treatment. Given this heterogeneity, we have based our suggestions bearing in mind some general factors There is not easy, universal solution to oncological care during this crisis and, to complicate matters, the duration of this pandemic is hard to predict. It is important to weigh the impact of each of our decisions in these trying times rather than rely on routine automatisms."],"journal":"ESMO Open","authors":["Banna, Giuseppe","Curioni-Fontecedro, Alessandra","Friedlaender, Alex","Addeo, Alfredo"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245904","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1136/esmoopen-2020-000765","keywords":["editorial"],"topics":["Treatment"],"weight":1,"_version_":1666138492056371203,"score":89.25062},{"pmid":32342047,"pmcid":"PMC7183963","title":"Recommendation to Optimize Safety of Elective Surgical Care While Limiting the Spread of COVID-19: Primum Non Nocere.","text":["Recommendation to Optimize Safety of Elective Surgical Care While Limiting the Spread of COVID-19: Primum Non Nocere.","COVID-19 has drastically altered our lives in an unprecedented manner, shuttering industries, and leaving most of the country in isolation as we adapt to the evolving crisis. Orthopedic surgery has not been spared from these effects, with the postponement of elective procedures in an attempt to mitigate disease transmission and preserve hospital resources as the pandemic continues to expand. During these turbulent times, it is crucial to understand that while patient and care-providers safety is paramount, canceling or postponing essential surgical care is not without consequences, and may be irreversibly detrimental to a patient's health and quality of life in some cases. The optimal solution of how to effectively balance the resumption of standard surgical care while doing everything possible to limit the spread of COVID-19 is undetermined, and could include strategies such as social distancing, screening forms and tests including temperature screening, segregation of inpatient and outpatient teams, proper use of protective gear, and the use of ambulatory surgery centers (ASCs) to provide elective, yet ultimately essential, surgical care while conserving resources and protecting the health of patients and health-care providers. Of importance, these recommendations do not and should not supersede evolving United States Centers for Disease Control and Prevention (CDC), and relevant federal, state and local public health guidelines. Level of Evidence: Level V.","Arthrosc Sports Med Rehabil","Gilat, Ron","Haunschild, Eric D","Tauro, Tracy","Cole, Brian J","32342047"],"abstract":["COVID-19 has drastically altered our lives in an unprecedented manner, shuttering industries, and leaving most of the country in isolation as we adapt to the evolving crisis. Orthopedic surgery has not been spared from these effects, with the postponement of elective procedures in an attempt to mitigate disease transmission and preserve hospital resources as the pandemic continues to expand. During these turbulent times, it is crucial to understand that while patient and care-providers safety is paramount, canceling or postponing essential surgical care is not without consequences, and may be irreversibly detrimental to a patient's health and quality of life in some cases. The optimal solution of how to effectively balance the resumption of standard surgical care while doing everything possible to limit the spread of COVID-19 is undetermined, and could include strategies such as social distancing, screening forms and tests including temperature screening, segregation of inpatient and outpatient teams, proper use of protective gear, and the use of ambulatory surgery centers (ASCs) to provide elective, yet ultimately essential, surgical care while conserving resources and protecting the health of patients and health-care providers. Of importance, these recommendations do not and should not supersede evolving United States Centers for Disease Control and Prevention (CDC), and relevant federal, state and local public health guidelines. Level of Evidence: Level V."],"journal":"Arthrosc Sports Med Rehabil","authors":["Gilat, Ron","Haunschild, Eric D","Tauro, Tracy","Cole, Brian J"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342047","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.asmr.2020.04.008","topics":["Prevention"],"weight":1,"_version_":1666138495093047296,"score":82.817986},{"pmid":32360422,"title":"Primum non nocere: Potential indirect adverse effects of COVID-19 containment strategies in the African region.","text":["Primum non nocere: Potential indirect adverse effects of COVID-19 containment strategies in the African region.","Travel Med Infect Dis","Wehrens, Erik","Bangura, James S","Falama, Abdul M","Kamara, Kelfala B B","Dubbink, Jan H","Bolkan, Hakon A","Grobusch, Martin P","32360422"],"journal":"Travel Med Infect Dis","authors":["Wehrens, Erik","Bangura, James S","Falama, Abdul M","Kamara, Kelfala B B","Dubbink, Jan H","Bolkan, Hakon A","Grobusch, Martin P"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360422","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.tmaid.2020.101727","topics":["Prevention"],"weight":1,"_version_":1666138495544983552,"score":82.817986},{"pmid":32287805,"pmcid":"PMC7130578","title":"Parallel problems.","text":["Parallel problems.","Our fight against climate change offers useful lessons for tackling the coronavirus.","New Sci","32287805"],"abstract":["Our fight against climate change offers useful lessons for tackling the coronavirus."],"journal":"New Sci","date":"2020-04-15T11:00:00Z","year":2020,"_id":"32287805","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S0262-4079(20)30471-1","topics":["General Info"],"weight":1,"_version_":1666138491402059777,"score":59.96414}]}